Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 12, 2007, Pages 1547-1556

  Liguori, A ^a   D'Armiento, F P ^b   Palagiano, A ^b   Balestrieri, M L ^b   Williams Ignarro, S ^c   De Nigris, F ^b   Lerman, L O ^d   D'Amora, M ^e   Rienzo, M ^b   Fiorito, C ^f   Ignarro, L J ^c   Palinski, W ^g   Napoli, C ^b,h  

^a Loreto Crispi Hospital   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Mayo Clinic   (United States)

^e Unit of Hepatology DH   (Italy)

^f IRCCS MULTIMEDICA   (Italy)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Developmental programming; Maternal hypercholesterolaemia; Oxidative stress; Placenta; Vascular reactivity

Indexed keywords

CHOLESTEROL; ENZYME; FATTY ACID; LEPTIN; LIPID;

ADULT; ARTICLE; BLOOD LEVEL; CESAREAN SECTION; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FATTY ACID TRANSPORT; FEMALE; GESTATIONAL HYPERCHOLESTEROLEMIA; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; LIPID COMPOSITION; MATERNAL BLOOD; NEWBORN; OMENTUM; OXIDATIVE STRESS; PLACENTA; PLACENTAL TRANSFER; PREGNANCY COMPLICATION; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; VAGINAL DELIVERY;

ADULT; ARTERIES; FATTY ACIDS; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LEPTIN; LIPID PEROXIDATION; LIPIDS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; OMENTUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; VASOCONSTRICTOR AGENTS; VASOMOTOR SYSTEM;

EID: 35948993336     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01510.x     Document Type: Article

References (48)

1. Woollett LA. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr 2005 82 : 1155 61.
2. Salameh WA, Mastrogiannis DS. Maternal hyperlipidemia in pregnancy. Clin Obstet Gynecol 1994 37 : 66 77.
3. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979 133 : 165 70.
4. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997 100 : 2680 90.
5. McConihay JA, Horn PS, Woollett LA. Effect of maternal hypercholesterolemia on fetal sterol metabolism in the Golden Syrian hamster. J Lipid Res 2001 42 : 1111 19.
6. Madsen EM, Lindegaard ML, Andersen CB, Damm P, Nielsen LB. Human placenta secretes apolipoprotein B-100-containing lipoproteins. J Biol Chem 2004 279 : 55271 6.
7. Napoli C, Witztum JL, Calara F, de Nigris F, Palinski W. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. Circ Res 2000 87 : 946 52.
8. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989 2 : 577 80.
9. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999 354 : 1234 41.
10. Palinski W, D'Armiento FP, Witztum JL, de Nigris F, Casanada F, Condorelli M, et al. Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits. Circ Res 2001 89 : 991 6.
11. Napoli C, de Nigris F, Welch JS, Calara FB, Stuart RO, Glass CK, et al. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation 2002 105 : 1360 7.
12. Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993 94 : 350 6.
13. Napoli C, Postiglione A, Triggiani M, Corso G, Palumbo G, Carbone V, et al. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia. Atherosclerosis 1995 118 : 259 73.
14. Yamashita T, Freigang S, Eberle C, Pattison J, Gupta S, Napoli C, et al. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res 2006 99 : E51 64.
15. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J 2002 16 : 1348 60.
16. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 1998 101 : 464 70.
17. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG. Contraction and endothelium-dependent relaxation in mesenteric microvessels from pregnant rats. Am J Physiol 1995 269 : H1899 904.
18. Hashimoto S. A new spectrophotometric assay method of xanthine oxidase in crude tissue homogenate. Anal Biochem 1974 62 : 426 35.
19. Napoli C, Witztum JL, de Nigris F, Palumbo G, D'Armiento FP, Palinski W. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 1999 99 : 2003 10.
20. Rodriguez-Porcel M, Lerman A, Best PJ, Krier JD, Napoli C, Lerman LO. Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol 2001 37 : 608 15.
21. Napoli C, Sica V, de Nigris F, Pignalosa O, Condorelli M, Ignarro LJ, et al. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J 2004 148 : e5.
22. Napoli C, D'Armiento FP, Corso G, Ambrosio G, Palumbo G, Zuliani P, et al. Occurrence of the same peroxidative compounds in low density lipoprotein and in atherosclerotic lesions from a homozygous familial hypercholesterolemic patient: a case report. Int J Cardiol 1997 62 : 77 85.
23. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990 10 : 325 35.
24. Palinski W, Hörkkö S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996 98 : 800 14.
25. Napoli C, Paterno R, Faraci FM, Taguchi H, Postiglione A, Heistad DD. Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits. Stroke 1997 28 : 2266 71.
26. de Nigris F, Williams-Ignarro S, Sica V, Lerman LO, D'Armiento FP, Byrns RE, et al. Effects of a Pomegranate Fruit Extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. Cardiovasc Res 2007 73 : 414 23.
27. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 193 : 265 75.
28. Coughlan MT, Vervaart PP, Permezel M, Georgiou HM, Rice GE. Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 2004 25 : 78 84.
29. Keaney JF Jr., Xu A, Cunningham D, Jackson T, Frei B, Vita JA. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 1995 95 : 2520 9.
30. Napoli C, de Nigris F, Palinski W. Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem 2001 82 : 674 82.
31. Ong SS, Baker PN, Mayhew TM, Dunn WR. No difference in structure between omental small arteries isolated from women with preeclampsia, intrauterine growth restriction, and normal pregnancies. Am J Obstet Gynecol 2002 187 : 606 10.
32. Innis SM. Essential fatty acid transfer and fetal development. Placenta 2005 26 (Suppl A S70 5.
33. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci U S A 1993 90 : 1073 7.
34. Koletzko B, Braun M. Arachidonic acid and early human growth: is there a relation? Ann Nutr Metab 1991 35 : 128 31.
35. Ip C, Jiang C, Thompson HJ, Scimeca JA. Retention of conjugated linoleic acid in the mammary gland is associated with tumor inhibition during the post-initiation phase of carcinogenesis. Carcinogenesis 1997 18 : 755 9.
36. Brodie AE, Manning VA, Ferguson KR, Jewell DE, Hu CY. Conjugated linoleic acid inhibits differentiation of pre- and post- confluent 3T3-L1 preadipocytes but inhibits cell proliferation only in preconfluent cells. J Nutr 1999 129 : 602 6.
37. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids 1997 32 : 853 8.
38. Domali E, Messinis IE. Leptin in pregnancy. J Matern Fetal Neonatal Med 2002 12 : 222 30.
39. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 1996 98 : 103 7.
40. Supnet MC, David-Cu R, Walther FJ. Plasma xanthine oxidase activity and lipid hydroperoxide levels in preterm infants. Pediatr Res 1994 36 : 283 7.
41. Evans HE, Rosenfeld W, Jhaveri R, Concepcion L, Zabaleta I. Oxidant-mediated lung disease in newborn infants. J Free Radic Biol Med 1986 2 : 369 72.
42. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994 344 : 721 4.
43. Maul H, Longo M, Saade GR, Garfield RE. Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr Pharm Des 2003 9 : 359 80.
44. Danielson LA, Conrad KP. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest 1995 96 : 482 90.
45. Williams DJ, Vallance PJ, Neild GH, Spencer JA, Imms FJ. Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 1997 272 : H748 52.
46. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ. Nitric oxide and atherosclerosis: an update. Nitric Oxide 2006 15 : 265 79.
47. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993 7 : 566 71.
48. Khoury J, Henriksen T, Seljeflot I, Morkrid L, Froslie KF, Tonstad S. Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study. BJOG 2007 114 : 279 88.